ATOSSA
Live / Applied — First extension granted (statement of use) (as of 30 Mar 2026)
What this means for you
Not registered yet, but its 15 Nov 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98855960
- Mark type
- Stylized text
- Filed
- 15 Nov 2024
- Published for opposition
- 10 Jun 2025
- Attorney of record
- Margaret McHugh
Goods and services
- Class 005 — Pharmaceuticals: Biological preparations for the treatment of breast cancer; Pharmaceutical preparations for the treatment of breast cancer; Medicinal preparations for the treatment of breast cancer
- Class 044 — Medical, beauty and agricultural services: Medical diagnosis and treatment of breast cancer
Owner
- Atossa Therapeutics, Inc., Seattle, WA, US
- Atossa Therapeutics, Inc., Seattle, WA, US
Prosecution history
- 31 Mar 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 30 Mar 2026 — SOU EXTENSION 1 GRANTED
- 30 Mar 2026 — SOU EXTENSION 1 FILED
- 30 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 30 Sept 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 10 Jun 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 10 Jun 2025 — PUBLISHED FOR OPPOSITION
- 04 Jun 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 12 May 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 12 May 2025 — ASSIGNED TO EXAMINER
- 26 Apr 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 13 Feb 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 13 Feb 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 13 Feb 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 13 Feb 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED